Department of Biology, Massachusetts Institute of Technology, 31 Ames St, Cambridge, MA 02142, USA.
Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA 02139, USA.
Glycobiology. 2020 May 19;30(6):374-381. doi: 10.1093/glycob/cwz105.
An in vitro gut-immune co-culture model with apical and basal accessibility, designed to more closely resemble a human intestinal microenvironment, was employed to study the role of the N-linked protein glycosylation pathway in Campylobacter jejuni pathogenicity. The gut-immune co-culture (GIC) was developed to model important aspects of the human small intestine by the inclusion of mucin-producing goblet cells, human enterocytes and dendritic cells, bringing together a mucus-containing epithelial monolayer with elements of the innate immune system. The utility of the system was demonstrated by characterizing host-pathogen interactions facilitated by N-linked glycosylation, such as host epithelial barrier functions, bacterial invasion and immunogenicity. Changes in human intestinal barrier functions in the presence of 11168 C. jejuni (wildtype) strains were quantified using GICs. The glycosylation-impaired strain 11168 ΔpglE was 100-fold less capable of adhering to and invading this intestinal model in cell infectivity assays. Quantification of inflammatory signaling revealed that 11168ΔpglE differentially modulated inflammatory responses in different intestinal microenvironments, suppressive in some but activating in others. Virulence-associated outer membrane vesicles produced by wildtype and 11168ΔpglE C. jejuni were shown to have differential composition and function, with both leading to immune system activation when provided to the gut-immune co-culture model. This analysis of aspects of C. jejuni infectivity in the presence and absence of its N-linked glycome is enabled by application of the gut-immune model, and we anticipate that this system will be applicable to further studies of C. jejuni and other enteropathogens of interest.
采用具有顶侧和基底可及性的体外肠道-免疫共培养模型,该模型旨在更接近人类肠道微环境,用于研究 N-连接蛋白糖基化途径在空肠弯曲菌致病性中的作用。肠道-免疫共培养(GIC)通过包含产生粘蛋白的 goblet 细胞、人肠上皮细胞和树突状细胞来模拟人类小肠的重要方面,将含有粘液的上皮单层与固有免疫系统的元素结合在一起。该系统的实用性通过表征 N-连接糖基化促进的宿主-病原体相互作用得到了证明,例如宿主上皮屏障功能、细菌入侵和免疫原性。在存在 11168 株空肠弯曲菌(野生型)的情况下,使用 GIC 定量评估人类肠道屏障功能的变化。糖苷化缺陷株 11168ΔpglE 在细胞感染测定中粘附和入侵这种肠道模型的能力降低了 100 倍。炎症信号的定量分析表明,11168ΔpglE 在不同的肠道微环境中差异调节炎症反应,在某些情况下抑制,在其他情况下激活。野生型和 11168ΔpglE 空肠弯曲菌产生的与毒力相关的外膜囊泡在组成和功能上存在差异,当提供给肠道-免疫共培养模型时,两者都导致免疫系统激活。在存在和不存在其 N-连接聚糖的情况下,对空肠弯曲菌感染性的这些方面进行分析是通过应用肠道-免疫模型实现的,我们预计该系统将适用于对空肠弯曲菌和其他相关肠道病原体的进一步研究。